time to clinical improvement; defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital; whichever comes first. <br/ > <br/ >3. Change in standard diagnosis: Serum c-reactive protein (CRP); IgG; Hb; Total leucocyte count and differential leucocyte count. <br/ >4. Change in urinary F2-Isoprostane from baseline to remission <br/ >Timepoint: Screening and Day14

time to clinical improvement; defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital; whichever comes first. <br/ > <br/ >3. Change in standard diagnosis: Serum c-reactive protein (CRP); IgG; Hb; Total leucocyte count and differential leucocyte count. <br/ >4. Change in urinary F2-Isoprostane from baseline to remission <br/ >Timepoint: Screening and Day14

N/A

N/A

time to clinical improvement; defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital; whichever comes first. <br/ > <br/ >3. Change in standard diagnosis: Serum c-reactive protein (CRP); IgG; Hb; Total leucocyte count and differential leucocyte count. <br/ >4. Change in urinary F2-Isoprostane from baseline to remission <br/ >Timepoint: Screening and Day14

time to clinical improvement; defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital; whichever comes first. <br/ > <br/ >3. Change in standard diagnosis: Serum c-reactive protein (CRP); IgG; Hb; Total leucocyte count and differential leucocyte count. <br/ >4. Change in urinary F2-Isoprostane from baseline to remission <br/ >Timepoint: Screening and Day14